| Akt signaling pathway in macrophage activation and M1/M2 polarization E Vergadi, E Ieronymaki, K Lyroni, K Vaporidi, C Tsatsanis The Journal of Immunology 198 (3), 1006-1014, 2017 | 833 | 2017 |
| Akt1 and Akt2 protein kinases differentially contribute to macrophage polarization A Arranz, C Doxaki, E Vergadi, Y Martinez de la Torre, K Vaporidi, ... Proceedings of the National Academy of Sciences 109 (24), 9517-9522, 2012 | 550 | 2012 |
| Akt2 deficiency protects from acute lung injury via alternative macrophage activation and miR-146a induction in mice E Vergadi, K Vaporidi, EE Theodorakis, C Doxaki, E Lagoudaki, ... The Journal of Immunology 192 (1), 394-406, 2014 | 170 | 2014 |
| Pulmonary microRNA profiling in a mouse model of ventilator-induced lung injury K Vaporidi, E Vergadi, E Kaniaris, M Hatziapostolou, E Lagoudaki, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 303 (3 …, 2012 | 119 | 2012 |
| ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with … C Papadaki, M Sfakianaki, G Ioannidis, E Lagoudaki, M Trypaki, ... Journal of Thoracic Oncology 7 (4), 663-671, 2012 | 86 | 2012 |
| Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer G Kallergi, EK Vetsika, D Aggouraki, E Lagoudaki, A Koutsopoulos, ... Therapeutic advances in medical oncology 10, 1758834017750121, 2018 | 72 | 2018 |
| Insulin resistance in macrophages alters their metabolism and promotes an M2-like phenotype E Ieronymaki, EM Theodorakis, K Lyroni, E Vergadi, E Lagoudaki, ... The Journal of Immunology 202 (6), 1786-1797, 2019 | 71 | 2019 |
| Clinical relevance of immune checkpoints on circulating tumor cells in breast cancer MA Papadaki, AV Koutsopoulos, PG Tsoulfas, E Lagoudaki, D Aggouraki, ... Cancers 12 (2), 376, 2020 | 62 | 2020 |
| PKM2 as a biomarker for chemosensitivity to front-line platinum-based chemotherapy in patients with metastatic non-small-cell lung cancer C Papadaki, M Sfakianaki, E Lagoudaki, G Giagkas, G Ioannidis, ... British journal of cancer 111 (9), 1757-1764, 2014 | 61 | 2014 |
| Detection and genotype analysis of human papillomavirus in non-small cell lung cancer patients E Sarchianaki, SP Derdas, M Ntaoukakis, E Vakonaki, ED Lagoudaki, ... Tumor Biology 35, 3203-3209, 2014 | 56 | 2014 |
| Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review T Konstantina, R Konstantinos, K Anastasios, M Anastasia, L Eleni, ... Lung cancer 135, 29-32, 2019 | 55 | 2019 |
| Upregulation of citrullination pathway: from autoimmune to idiopathic lung fibrosis KD Samara, A Trachalaki, E Tsitoura, AV Koutsopoulos, ED Lagoudaki, ... Respiratory research 18, 1-10, 2017 | 55 | 2017 |
| Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung … C Papadaki, E Tsaroucha, L Kaklamanis, E Lagoudaki, M Trypaki, ... British journal of cancer 104 (2), 316-323, 2011 | 44 | 2011 |
| Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with … N Karachaliou, C Papadaki, E Lagoudaki, M Trypaki, M Sfakianaki, ... PLoS One 8 (9), e74611, 2013 | 42 | 2013 |
| Novel oligomeric proanthocyanidin derivatives interact with membrane androgen sites and induce regression of hormone-independent prostate cancer M Kampa, K Theodoropoulou, F Mavromati, V Pelekanou, G Notas, ... Journal of Pharmacology and Experimental Therapeutics 337 (1), 24-32, 2011 | 40 | 2011 |
| Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer I Messaritakis, E Politaki, A Kotsakis, EK Dermitzaki, F Koinis, ... PLoS One 12 (7), e0181211, 2017 | 35 | 2017 |
| Bcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatment I Messaritakis, M Nikolaou, E Politaki, F Koinis, E Lagoudaki, ... Lung Cancer 124, 270-278, 2018 | 28 | 2018 |
| TTF-1-and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC) I Messaritakis, D Stoltidis, A Kotsakis, EK Dermitzaki, F Koinis, ... Scientific reports 7 (1), 45351, 2017 | 28 | 2017 |
| Aberrant expression of miR-21, miR-376c and miR-145 and their target host genes in Merkel cell polyomavirus-positive non-small cell lung cancer I Lasithiotaki, E Tsitoura, A Koutsopoulos, E Lagoudaki, C Koutoulaki, ... Oncotarget 8 (68), 112371-83, 2017 | 27 | 2017 |
| The prognostic value of JUNB-positive CTCs in metastatic breast cancer: from bioinformatics to phenotypic characterization G Kallergi, V Tsintari, S Sfakianakis, E Bei, E Lagoudaki, A Koutsopoulos, ... Breast Cancer Research 21, 1-13, 2019 | 24 | 2019 |
